Because it's so important that patients get off to the right start with COPAXONE®, Teva’s Shared Solutions® provides free in-home initial injection training, so you can be confident that they are in supportive hands and encouraged to be compliant from the beginning.
Teva-trained nurses conducted 22,913 injection trainings in 2016.
Teva’s Shared Solutions® cares about your patients' COPAXONE® therapy experience and provides ongoing, in-home refresher injection training from Teva-trained nurses whenever they need it, at any stage of therapy. You can be confident that they are getting the continued face-to-face support that will help them stay compliant throughout their therapy experience.View downloadable injection training and tracking tools available for your patients
A small change can make a big difference
Injections for 3-times-a-week COPAXONE® 40 mg must be at least 48 hours apart.
COPAXONE® is contraindicated in patients with known hypersensitivity to glatiramer acetate or mannitol.
Approximately 16% of patients exposed to COPAXONE® 20 mg per mL compared to 4% of those on placebo, and approximately 2% of
The website you are about to visit does not belong to Teva Neuroscience, Inc. or follow the same terms of service. Some of these websites may also require a third-party account, subscription, or payment to view.
While we carefully choose which websites we link to, we cannot control any changes or actions made by them. As a result, Teva makes no warranties or representations of any kind as to the accuracy, currency, or completeness of the following site, nor any liability on their behalf.